E7070 in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 1998

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

indisulam

Trial Locations (26)

31052

Institut Claudius Regaud, Toulouse

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

63011

Centre Jean Perrin, Clermont-Ferrand

69373

Centre Leon Berard, Lyon

A-6020

Innsbruck Universitaetsklinik, Innsbruck

A-1100

Kaiser Franz Josef Hospital, Vienna

B-1000

Institut Jules Bordet, Brussels

B-1200

Ludwig Institute for Cancer Research, Brussels

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

B-3000

U.Z. Gasthuisberg, Leuven

DK-2730

Herlev Hospital - University Hospital of Copenhagen, Copenhagen

F-94805

Institut Gustave Roussy, Villejuif

D-45122

Universitaetsklinikum Essen, Essen

1001HV

Vrije Universiteit Medisch Centrum, Amsterdam

1066 CX

Antoni van Leeuwenhoekhuis, Amsterdam

9700 RB

Academisch Ziekenhuis Groningen, Groningen

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

3008 EA

Erasmus University Medical Center, Rotterdam

N-0310

Norwegian Radium Hospital, Oslo

CH-4031

University Hospital, Basel

CH-3010

Inselspital, Bern, Bern

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

NE4 6BE

Newcastle General Hospital, Newcastle upon Tyne

SM2 5PT

Royal Marsden Hospital, Sutton

DD1 9SY

Ninewells Hospital and Medical School, Dundee

EH4 2XU

Western General Hospital, Edinburgh

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00003981 - E7070 in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter